Industrial Biotechnology Association
Executive Summary
Mycogen CEO Jerry Caulder elected chairman of the biotech trade group for 1989-90. He succeeds Schering-Plough Exec VP-Administration Hugh D'Andrade, who will remain on the association's board. Caulder identified some of the key industry issues as health care reimbursement, protection of intellectual property rights, the patent backlog and the release of genetically engineered organisms. Other officers elected to one-year terms are Vice Chairman Stephen Duzan, president, Immunex; Merck Senior VP Charles Leighton, secretary; Calgene CEO Roger Salquist, treasurer; and President Richard Godown. All but Godown also serve as IBA directors.